IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

347.00

Prev. Close

350.15

Turnover (lac.)

27,593

Day's High

363.60

Day's Low

345.00

52 Week's High

596.30

52 Week's Low

161.65

Book Value

459

Face Value

1

Mkt Cap (Cr.)

9,933

P/E

7.72

EPS

45.59

Divi. Yield

0.57

Glenmark Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glenmark Pharmaceuticals LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd469.4036.04112,576.80468.760.592,920.8398.33
Dr Reddys Laboratories Ltd3,892.8522.0364,714.06502.800.642,837.90914.23
Divis Laboratories Ltd2,320.0048.5861,712.15360.730.691,390.49266.77
Cipla Ltd639.3522.2351,518.69604.570.633,042.01215.85
Torrent Pharmaceuticals Ltd2,601.0047.0643,995.51220.000.651,436.00323.64

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glenmark Pharmaceuticals LtdSummary & Reports

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by glenmark-pharmaceuticals-ltd

View

- <

Reco. Price

May 12,2020 10:33 AM

Target Price

Target Returns:

0.00%

Result Express

Glenmark Pharmaceuticals Ltd's Q2FY19 consolidated net profit rises 15.27% yoy to Rs246.82cr : Beats Estimates

May 25, 2020 08:18 AM

The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    14 Feb 2020

    Annc. Date

    31 Jan 2020

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More

  • Purpose

    Board Meeting

    Exp. Date

    14 Nov 2019

    Annc. Date

    05 Nov 2019

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More